| Request Type |
New Registration
|
|---|---|
| Drug Type |
Generic(Multisource) Drug
|
| Trade Name |
Tasylev
|
| Scientific Name |
semaglutide
|
| Strength |
0.25 mg
|
| Dosage Form |
Solution for injection in pre-filled pen
|
| SFDA Approved Use |
Tasylev is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise
•As monotherapy when metformin is considered inappropriate due to intolerance or contraindications •In addition to other medicinal products for the treatment of diabetes. •Tasylev is indicated to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction or non-fatal stroke) in adults with type 2 diabetes mellitus and established cardiovascular disease. |
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
Tue 13 Oct 2026
Beta version
Official Saudi government website domains end with gov.sa
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Official Reliable websites use HTTPS
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.